Pharmed Salamat Sina

Pharmed Salamat Sina is an Iranian biotechnology company specializing in the development and manufacture of high-tech biopharmaceutical products, particularly biosimilars. The company focuses on therapeutic areas such as oncology, endocrinology, and hematology. Its portfolio includes recombinant proteins and peptide-based drugs, with notable products like Peclyra (pegfilgrastim) for chemotherapy-induced neutropenia and SinaPar (teriparatide) for osteoporosis. Pharmed Salamat Sina operates as a knowledge-based enterprise, contributing to the domestic production of critical medicines within the Iranian healthcare system. The company maintains advanced manufacturing facilities compliant with regional standards to ensure the supply of essential biologics.